New study aims to speed up detection of dangerous hospital bacteria
NCT ID NCT07397416
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a faster genetic test (PCR) can help hospitals detect a dangerous bacteria called CPE more quickly than the current lab method, which takes up to 48 hours. Researchers will compare how long it takes to start or stop patient isolation using each method in about 800 adults admitted to a hospital in Argentina. The goal is to see if the rapid test can reduce delays and improve infection control without needing to change current practices.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 800 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Mar 2026
An estimate. Start dates often move.
- Expected to finish
-
May 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adult patients aged ≥18 years * Patients screened for carbapenemase-producing Enterobacterales (CPE) carriage by perianal swab within the first 5 days of hospital admission * Patients newly identified as CPE-colonized, leading to initiation of contact isolation * Patients found to be decolonized, leading to discontinuation of contact isolation * Patients with indication for active surveillance at hospital admission: * Transfer from another healthcare facility * Hospitalization in another healthcare center within the previous month * Patients undergoing active surveillance during hospitalization: * First surveillance swab in high-risk neutropenic patients (HAR flag) * First surveillance swab in immunosuppressed units, such as hematopoietic stem-cell transplant wards * Patients evaluated for discontinuation of contact precautions who meet all of the following: * Prior CPE-positive surveillance sample * At least 3 months since the last positive result and last hospitalization * No systemic antibiotic exposure during that period Exclusion Criteria: * Lost samples * Insufficient samples * Invalid laboratory test results requiring repeat sampling
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Carbapenemase-producing enterobacterales (CPE) colonization are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.